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Music therapy in patients with dementia and
behavioral disturbance on an inpatient
psychiatry unit: results from a pilot randomized
controlled study
Background
The prevalence of dementia continues to grow
worldwide due to an aging population and is
projected to affect 65.7 million people by 2030
(World Health Organization, 2012). Behavioral
and psychological symptoms of dementia (BPSD),
including agitation, anxiety, aggression, depression,
and psychosis, can occur in as much as 80% of
the affected population, frequently necessitating
psychiatric admission. Traditionally BPSD have
been treated using pharmacological approaches.
However, such medications could have serious
adverse effects and additionally have limited
efficacy in reducing such symptoms (Ballard et al.,
2009).
There is some evidence that music therapy (MT)
may be an effective non-pharmacological treatment
for BPSD as it has been shown to reduce aggressive
behavioral symptoms and anxiety, while improving
mood and quality of life in patients with dementia
residing in nursing homes (Chang et al., 2010; Vink
et al., 2013). However, there is no evidence of MT
offering benefit in this population in a psychiatric
unit. The aim of this pilot randomized controlled
study is to determine the feasibility and effectiveness
of MT on BPSD in patients with dementia in an
acute psychiatric inpatient setting.
Methodology
Approval was received from the Western University
Research Ethics Board. Participants were recruited
from patients over the age of 50 years with an
ICD-10 diagnosis of dementia admitted to an acute
inpatient psychiatric unit within a large academic
hospital in Ontario, Canada. Additional inclusion
criteria encompassed scores of 13 on the Mini-
Mental State Examination, indicating a baseline
of moderate to severe cognitive impairment, 2
on the Clinical Dementia Rating (CDR) scale, 3
on distressing behaviors from the Neuropsychiatric
Inventory-Clinician version (NPI-C) and 45
on the Cohen-Mansfield Agitation Inventory
(CMAI).
Participants were recruited for the study by
AV, the investigator psychiatrist, who provided the
letter of information and evaluated the patient’s
competency to consent. Of the patients approached,
only 3 (19%) were assessed to be competent to
provide consent themselves; 13 participants (81%)
had consent provided by their substitute decision
maker (SDM). In the province of Ontario, the
patient’s SDM is responsible for understanding the
details of a particular treatment and recognizing the
consequences of choosing it or not.
Participants were randomized to either a MT
treatment group or Active Engagement Intervention
(AEI) using an online randomization program.
The sequence of allocation was concealed from
the inpatient staff and clinical raters. A power
calculation was completed using α of 0.05 and
power of 80%, which required 16 participants in
each group to identify a difference of one standard
deviation between the mean total CMAI scores
between the two groups.
Participants in the MT group received up to
eight hours of face-to-face MT from an accredited
music therapist over four weeks of bi-weekly,
hour-long sessions. All MT and AEI sessions
were completed individually. The participants were
encouraged to actively engage in the musical
process and to follow the music therapist’s
lead. Participants were provided with specific
instructions on how to participate by singing and/or
playing simple instruments, including maracas
and small drums. The music was selected in
accordance with participant preferences and was
of a calming nature. The music therapist indicated
that most participants engaged in a meaningful
way. Participants in the AEI group received up to
eight hours of active engagement and attention from
a social worker, including supportive interviewing
and encouragement of expression through simple
occupational activities including folding towels and
browsing magazines.
Change in severity of BPSD was assessed using
the NPI-C and CMAI for each participant, at
baseline and weekly, within 24 hours of the last
session, for up to four weeks. Raters came from
a pool of trained outpatient psychiatric nurses and
social workers masked to treatment allocation. Data
were analyzed using a mixed model analysis of
variance with repeated measures using IBM SPSS
21 (IBM Corp., USA). If patients participated
in less than the eight sessions, all outcome data
were treated as Last Observation Carried Forward
(LOCF).
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Results
A total of 25 participants were screened, of whom
9 did not meet eligibility criteria. Of the 16
participants recruited to the study, 10were allocated
to the MT group and 6 to the AEI group. From the
sample, 11 (69%) were diagnosed with Alzheimer’s
Dementia, 3 (19%) with Vascular Dementia, and
2 (13%) with Dementia with Lewy Bodies. The
mean ± SD age of participants in the MT group
was 83.5 ± 7.7 years and 68.4 ± 5.2 years
in the AEI group (p < 0.05). Other than the
age of participants, treatment arms did not differ
significantly with respect to gender, education,
marital status, type of residence at admission,
number of past psychiatric admissions, smoking
status, and extent of medical comorbidities. All of
the participants received at least one psychotropic
medication during their hospital admission. The
commonest psychotropics, used by 25% or more
participants, included Haloperidol, Quetiapine,
Risperidone, and Trazodone. At baseline, the mean
± SDMMSE score was 7.3± 6.3 in theMT group,
and 5.7 ± 3.4 in the AEI group (p = 0.59), while
the mean ± SD CDR score was 16.7 ± 2.4 in the
MT group and 17.0 ± 0.8 in the AEI group (p =
0.80).
The baseline mean ± SD CMAI score was 67.8
± 17.1 in the MT and 64.2 ± 19.5 in the AEI
groups. We observed a non-significant decrease in
the CMAI scores in both theMT (54.3± 12.8) and
AEI (56.2 ± 20.4) groups after the first week (p >
0.05). However, there was subsequent deterioration
on the CMAI scores over the following three weeks;
at the end of study period, scores were 84.3 ±
28.7 in the MT group and 79.0 ± 34.1 in the AEI
group.
Mean total NPI-C and Caregiver Distress scores
were higher for the MT group at both baseline (MT
= 38.2 ± 24.3, 11.8 ± 5.9 vs. AEI = 32.8 ± 12.9,
8.8 ± 5.8) and after one week (MT = 30.2 ±
15.9, 6.9 ± 5.3 vs. AEI = 25.3 ± 12.5, 6.2 ± 1.6)
but there were no significant differences (p > 0.05)
between treatment groups at any of the time points.
Some of the individual behavior items, including
delusions, elation, and motor disturbances, showed
differences between the treatment groups; however,
these were inconsistent in both direction of effect
and relationship with time.
Discussion
It is realistic to offer MT to patients with BPSD
on a busy inpatient psychiatry unit; however, our
pilot data suggest that it may not be superior to
active engagement. These results seem to contradict
current evidence showing the benefit of MT for
individuals with BPSD in nursing home settings.
The lack of benefit of MT in our study could
be related to the more severely affected sample
as reflected by the high baseline CMAI and NPI-
C scores. We suspect participants were unable to
meaningfully engage in the intervention.
The major limitation of this study is the
small sample size, as only 16 participants were
recruited before human resource changes in the
psychiatric inpatient unit made further recruitment
untenable. It is possible that the study was further
underpowered as previous research indicates effect
sizes of MT equal to approximately half an SD
(Ueda et al., 2013), requiring a sample of 55
participants in each arm. However, we felt that
a single SD difference would be considered more
clinically relevant. Regardless, future studies aiming
to investigate MT in acute psychiatric inpatient
settings would likely need to be multi-centered
due to the difficulty in recruiting sufficient eligible
participants. A second limitation was the varying
duration of patient stay and treatment. A number of
the patients enrolled in this study were hospitalized
for two to three weeks, which limited the amount of
data that could be collected. Finally, the intention
of this controlled trial was to have participants
engage with one another during treatment sessions.
However, due to the small sample size and
availability of patients who met the eligibility
criteria, MT sessions occurred individually on all
occasions.
Additional large scale RCTs are needed to
assess if MT does improve BPSD in patients with
dementia in acute psychiatric care. There were no
adverse events experienced by the participants in
either group, which supports the future potential for
therapeutic benefits gleaned from additional RCTs.
Subsequent studies should consider increasing the
frequency of therapy sessions to see if the initial
benefits of the therapy are sustained. Our results can
be considered preliminary evidence of the feasibility
of MT interventions in acute care settings.
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